Middle East & Africa Central Nervous System Therapeutic Market Size & Outlook
Middle East & Africa central nervous system therapeutic market, 2018-2028 (US$M)
Related Markets
MEA central nervous system therapeutic market highlights
- The MEA central nervous system therapeutic market generated a revenue of USD 3,911.9 million in 2020.
- The market is expected to grow at a CAGR of 5.2% from 2021 to 2028.
- In terms of segment, mental health was the largest revenue generating disease in 2020.
- CNS Cancer is the most lucrative disease segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2021 to 2028.
MEA data book summary
| Market revenue in 2020 | USD 3,911.9 million |
| Market revenue in 2028 | USD 5,884.8 million |
| Growth rate | 5.2% (CAGR from 2020 to 2028) |
| Largest segment | Mental health |
| Fastest growing segment | CNS Cancer |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer |
| Key market players worldwide | Biogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.7% of the global central nervous system therapeutic market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 43,984.7 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Central Nervous System Therapeutic Market Scope
Central Nervous System Therapeutic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa central nervous system therapeutic market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.
Mental health was the largest segment with a revenue share of 52.4% in 2020. Horizon Databook has segmented the Middle East & Africa central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.
The Middle East and North African region have reported to have high rates of mental disorders. For instance, Epidemiology studies in the North African and Middle Eastern regions have demonstrated depression rates, ranging from 13 % to 18%, respectively,
with women experiencing almost double the rates of depression as compared to men. Moreover, recent studies consisting of Arab youth across 15 countries of Middle East and North Africa found that one-third of the interviewees were suffering from a mental disorder such as depression or anxiety.
Reasons to subscribe to Middle East & Africa central nervous system therapeutic market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa central nervous system therapeutic market databook
-
Our clientele includes a mix of central nervous system therapeutic market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa central nervous system therapeutic market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
MEA central nervous system therapeutic market size, by country, 2018-2028 (US$M)
Middle East & Africa Central Nervous System Therapeutic Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
